Key Financial Data Of Group

ONO PHARMACEUTICAL CO., LTD. - Filing #7732427

Concept 2017-07-01 to
2017-09-30
2017-04-01 to
2017-09-30
As at
2017-09-30
2016-04-01 to
2017-03-31
As at
2017-03-31
2016-07-01 to
2016-09-30
As at
2016-09-30
2016-04-01 to
2016-09-30
Key financial data of group
Business results of group
Revenue
60,533,000,000 JPY
121,446,000,000 JPY
244,797,000,000 JPY
58,969,000,000 JPY
117,726,000,000 JPY
Profit (loss) before tax
28,393,000,000 JPY
74,540,000,000 JPY
31,127,000,000 JPY
Profit (loss), attributable to owners of parent
9,435,000,000 JPY
21,210,000,000 JPY
55,793,000,000 JPY
9,439,000,000 JPY
23,119,000,000 JPY
Comprehensive income
32,418,000,000 JPY
68,083,000,000 JPY
23,839,000,000 JPY
Equity attributable to owners of parent
502,086,000,000 JPY
519,110,000,000 JPY
485,620,000,000 JPY
Total assets
576,599,000,000 JPY
617,461,000,000 JPY
557,753,000,000 JPY
Basic earnings (loss) per share
18.28
40.63
105.27
17.81
43.62
Diluted earnings (loss) per share
18.28
40.63
105.26
17.81
43.62
Ratio of owners' equity to gross assets
0.871 xbrli:pure
0.841 xbrli:pure
0.871 xbrli:pure
Cash flows from (used in) operating activities
-10,382,000,000 JPY
74,450,000,000 JPY
23,863,000,000 JPY
Cash flows from (used in) investing activities
-36,147,000,000 JPY
-17,989,000,000 JPY
-28,341,000,000 JPY
Cash flows from (used in) financing activities
-49,591,000,000 JPY
-20,552,000,000 JPY
-9,746,000,000 JPY
Cash and cash equivalents
50,272,000,000 JPY
146,323,000,000 JPY
95,584,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.